Abstract:Hepatic ischemia/reperfusion injury (HIRI) is a complex pathophysiological process that often leads to poor clinical prognosis. Clinically, the effective means to alleviate HIRI are limited. The aim of the present study was to investigate whether Alda‑1, an activator of mitochondrial aldehyde dehydrogenase 2 (ALDH2), had a protective effect on HIRI and to investigate the mechanisms underlying this protective effect. Sprague‑Dawley rats were treated with Alda‑1 or Daidzin, an ALDH2 inhibitor, 30 min before partial (70%) warm liver ischemia to induce HIRI. The 48 rats were randomly divided into four groups: Sham, ischemia injury (IR), IR‑Alda‑1, and IR‑Daidzin. After 6 and 24 h of reperfusion, serum and liver tissue samples were collected and stored for further experiments. Alanine aminotransferase, aspartate aminotransferase and hematoxylin & eosin staining was used to evaluate the liver damage. Western blotting and reverse transcription‑quantitative PCR were used to detect the expression of related proteins and mRNA. TUNEL staining was used to observe the apoptosis of liver cells. Transmission electron microscopy was used to detect the mitochondrial injuries. Alda‑1 pretreatment ameliorated the HIRI‑induced damage to the liver function and reduced histological lesions. Alda‑1 also increased ALDH2 activity after HIRI. Moreover, the pretreatment with Alda‑1 reduced the accumulation of toxic aldehyde 4‑hydroxy‑2‑nonenal, decreased the production of reactive oxygen species and malondialdehyde, reversed the damage to the liver mitochondria, attenuated hepatocyte apoptosis and inhibited the HIRI‑induced inflammatory response, including high‑mobility group box 1/toll‑like receptor 4 signaling. Alda‑1 also induced autophagy by upregulating autophagy‑related 7 and Rab7 increasing the microtubule associated protein 1 light chain 3 αII/I ratio and inhibiting p62 expression. ALDH2‑induced autophagy was dependent on the activation of the AKT/mammalian target of rapamycin (mTOR) and AMP‑activated protein kinase (AMPK) signaling pathways. In conclusion, the findings of the present study suggested that Alda‑1 may protect the liver against HIRI‑induced damage, including hepatic enzyme injury, acetaldehyde accumulation, oxidative stress, hepatocyte apoptosis and inflammation. Alda‑1 may confer this protection by inducing autophagy through the AKT/mTOR and AMPK signaling pathways. Therefore, ALDH2 could represent a potential pharmacological target in the clinical treatment of HIRI.

ROLE OF ALDH2 IN PROTECTION OF NG108-15 NEURAL CELLS AGAINST HYPOXIA/REOXYGENATION-INDUCED INJURY

Characterization of the Molecular Mechanisms Underlying Increased Ischemic Damage in the Aldehyde Dehydrogenase 2 Genetic Polymorphism Using a Human Induced Pluripotent Stem Cell Model System.

ALDH 2 conferred neuroprotection on cerebral ischemic injury by alleviating mitochondria-related apoptosis through JNK/caspase-3 signing pathway.

Alda-1 treatment promotes the therapeutic effect of mitochondrial transplantation for myocardial ischemia-reperfusion injury

Alda-1 Reduces Cerebral Ischemia/reperfusion Injury in Rat Through Clearance of Reactive Aldehydes.

ALDH2 activation attenuates oxygen–glucose deprivation/reoxygenation-induced cell apoptosis, pyroptosis, ferroptosis and autophagy

Mitochondrial aldehyde dehydrogenase, a potential drug target for protection of heart and brain from ischemia/reperfusion injury.

Aldehyde Dehydrogenase 2 Overexpression Inhibits Neuronal Apoptosis after Spinal Cord Ischemia/Reperfusion Injury

Alda-1, an ALDH2 activator, protects against hepatic ischemia/reperfusion injury in rats via inhibition of oxidative stress

ALDH2 protects against stroke by clearing 4-HNE

Aldehyde Dehydrogenase 2 (ALDH2) Rescues Myocardial Ischaemia/reperfusion Injury: Role of Autophagy Paradox and Toxic Aldehyde

Alda-1 Attenuates Lung Ischemia-Reperfusion Injury by Reducing 4-Hydroxy-2-Nonenal in Alveolar Epithelial Cells.

Aldehyde Dehydrogenase 2 Protects Against Post-Cardiac Arrest Myocardial Dysfunction Through a Novel Mechanism of Suppressing Mitochondrial Reactive Oxygen Species Production.

Aldehyde Dehydrogenase 2 Has Cardioprotective Effects on Myocardial Ischaemia/Reperfusion Injury Via Suppressing Mitophagy

Aldehyde Dehydrogenase 2 Preserves Mitochondrial Function in the Ischemic Heart: A Redox-dependent Mechanism for AMPK Activation by Thioredoxin-1

Role of aldehyde dehydrogenase 2 in ischemia reperfusion injury: An update

Pharmacological Activation Of Aldehyde Dehydrogenase 2 Protects Against Heatstroke-Induced Acute Lung Injury by Modulating Oxidative Stress and Endothelial Dysfunction

Aldehyde Dehydrogenase 2 Preserves Mitochondrial Morphology and Attenuates Hypoxia/reoxygenation-Induced Cardiomyocyte Injury.

Aldo-keto reductases mediate constitutive and inducible protection against aldehyde toxicity in human neuroblastoma SH-SY5Y cells.

Pretreatment with the ALDH2 activator Alda‐1 protects rat livers from ischemia/reperfusion injury by inducing autophagy

Mitochondrial Aldehyde Dehydrogenase-2 Deficiency Compromises Therapeutic Effect of ALDH Bright Cell on Peripheral Ischemia.